会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NOVEL DERIVATIVES OF PYRROLOINDOLE WHICH ARE INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME, AND USE THEREOF
    • 作为HSP90的抑制剂的吡咯烷的新型衍生物,其组合物及其用途
    • US20110184015A1
    • 2011-07-28
    • US12970458
    • 2010-12-16
    • Marcel AlasiaHervé MinouxJean-Marie Ruxer
    • Marcel AlasiaHervé MinouxJean-Marie Ruxer
    • A61K31/437C07D471/04A61P25/16A61P25/28A61P31/12A61P27/02A61P17/06A61P13/00A61P35/00
    • C07D519/00A61K31/13Y02A50/385Y02A50/411
    • Pyrroloindoles of formula (I) are provided wherein Het is an aromatic or partially unsaturated, monocyclic or bicyclic heterocycle containing between 1 and 4 heteroatoms N, O or S, optionally substituted by R1 or R′1 which are the same or different; R is X-(A-B)n-CONH2, X-(A-B)n-O—CONH2, X-(A-B)n-NH—CONH2, X—(CH2)m-heterocycloalkyl, X(CH2)m-aryl and X—(CH2)m-heteroaryl wherein X is —O—C(O), —NH—C(O), NH—CS, —NH—CO—CH2-O—; —NH—COCH2-S—CH2-CO—NH—; —NH—CO—(CH2)2-SO2-; and —NH—CO—CH2-N(CH3)-CO—; A and B are the same or different and are each independently a single bond, CH2, CH-alkyl, and CH-aralkyl; n=1,2 and m=0, 1; R1 and/or R′1 are H, halogen, CF3, nitro, cyano, alkyle, hydroxy, mercapto, amino, alkylamino, dialkylamino, alkoxy, alkylthio, and carboxy, free or esterified by an alkyl, carboxamide, CONH(alkyl), CON(alkyl)2, NH—CO-alkyl, sulfonamide, NH—SO2-alkyl, S(O)2-NHalkyl, and S(O2)-N(alkyl)2 group, all of said alkyl, alcoxy and alkylthio groups being optionally substituted themselves, said products being in all isomer forms and salts, as medicaments.
    • 提供式(I)的吡咯并吲哚,其中Het是含有1至4个杂原子N,O或S的芳族或部分不饱和的单环或双环杂环,任选被相同或不同的R1或R'1取代; R是X-(AB)n-CONH 2,X-(AB)n O-CONH 2,X-(AB)n -NH-CONH 2,X-(CH 2)m-杂环烷基, (CH 2)m - 杂芳基,其中X是-O-C(O),-NH-C(O),NH-CS,-NH-CO-CH 2 -O- -NH-COCH 2 -S-CH 2 -CO-NH-; -NH-CO-(CH 2)2 -SO 2 - ; 和-NH-CO-CH 2 -N(CH 3)-CO-; A和B相同或不同,各自独立地为单键,CH 2,CH-烷基和CH-芳烷基; n = 1,2和m = 0,1; R 1和/或R'1是烷基,羧酰胺,CONH(烷基)烷基,C 1 -C 6烷基,C 1 -C 6烷基, ,CON(烷基)2,NH-CO-烷基,磺酰胺,NH-SO 2 - 烷基,S(O)2 -NH烷基和S(O 2)-N(烷基)2基团,所有烷基,烷氧基和烷硫基 基团任选地被取代,所述产物是所有异构体形式和盐,作为药物。
    • 6. 发明授权
    • Derivatives of pyrroloindole which are inhibitors of Hsp90, compositions containing same, and use thereof
    • 作为Hsp90抑制剂的吡咯并吲哚的衍生物,含有它们的组合物及其用途
    • US08178687B2
    • 2012-05-15
    • US12970458
    • 2010-12-16
    • Marcel AlasiaHervé MinouxJean-Marie Ruxer
    • Marcel AlasiaHervé MinouxJean-Marie Ruxer
    • C07D215/38
    • C07D519/00A61K31/13Y02A50/385Y02A50/411
    • Pyrroloindoles of formula (I) are provided wherein Het is an aromatic or partially unsaturated, monocyclic or bicyclic heterocycle containing between 1 and 4 heteroatoms N, O or S, optionally substituted by R1 or R′1 which are the same or different; R is X-(A-B)n-CONH2, X-(A-B)n-O—CONH2, X-(A-B)n-NH—CONH2, X—(CH2)m-heterocycloalkyl, X(CH2)m-aryl and X—(CH2)m-heteroaryl wherein X is —O—C(O), —NH—C(O), NH—CS, —NH—CO—CH2-O—; —NH—COCH2-S—CH2-CO—NH—; —NH—CO—(CH2)2-SO2-; and —NH—CO—CH2-N(CH3)-CO—; A and B are the same or different and are each independently a single bond, CH2, CH-alkyl, and CH-aralkyl; n=1, 2 and m=0, 1; R1 and/or R′1 are H, halogen, CF3, nitro, cyano, alkyle, hydroxy, mercapto, amino, alkylamino, dialkylamino, alkoxy, alkylthio, and carboxy, free or esterified by an alkyl, carboxamide, CONH(alkyl), CON(alkyl)2, NH—CO-alkyl, sulfonamide, NH—SO2-alkyl, S(O)2-NHalkyl, and S(O2)-N(alkyl)2 group, all of said alkyl, alcoxy and alkylthio groups being optionally substituted themselves, said products being in all isomer forms and salts, as medicaments.
    • 提供式(I)的吡咯并吲哚,其中Het是含有1至4个杂原子N,O或S的芳族或部分不饱和的单环或双环杂环,任选被相同或不同的R1或R'1取代; R是X-(AB)n-CONH 2,X-(AB)n O-CONH 2,X-(AB)n -NH-CONH 2,X-(CH 2)m-杂环烷基, (CH 2)m - 杂芳基,其中X是-O-C(O),-NH-C(O),NH-CS,-NH-CO-CH 2 -O- -NH-COCH 2 -S-CH 2 -CO-NH-; -NH-CO-(CH 2)2 -SO 2 - ; 和-NH-CO-CH 2 -N(CH 3)-CO-; A和B相同或不同,各自独立地为单键,CH 2,CH-烷基和CH-芳烷基; n = 1,2,m = 0,1; R 1和/或R'1是烷基,羧酰胺,CONH(烷基)烷基,C 1 -C 6烷基,C 1 -C 6烷基, ,CON(烷基)2,NH-CO-烷基,磺酰胺,NH-SO 2 - 烷基,S(O)2 -NH烷基和S(O 2)-N(烷基)2基团,所有烷基,烷氧基和烷硫基 基团任选地被取代,所述产物是所有异构体形式和盐,作为药物。